• Jump to content
  • RSS News Feed
  • Member Login
Medicines Australia

Medicines Australia

  • Home
  • About Us
  • Media | Events
  • Issues | Information
  • Code of Conduct
  • Links
  • You are here:
  • Home
  • Issues | Information
  • PBS Agreements

Issues | Information

  • Clinical Trials
    • Clinical Trials Research Agreements
    • Indemnity & Compensation Guidelines
  • Core CMI
  • Innovation & Industry Policy
    • R&D Tax Credit
    • Clinical Trials Action Group
    • Gene Patents
    • Patent Reform
    • Data Exclusivity
    • TRIPS Protocol
  • PBS Agreements
  • Publications
    • Economic Survey
    • Facts Book
    • Medicines Matter
    • Occasional Papers
    • Other
    • Reports
      • Archived Reports
    • Submissions
  • Vaccines
    • What is a vaccine?
    • Value
    • Immunisation
    • Requirements and safety
    • Role of industry
  • Archives
    • Election 2010

PBS Agreements

PBS Deferrals

  • Pharmaceutical Benefits Scheme Deferrals Statement of principles of commitment between stakeholders  69k
  • PBS Amendments 2012 – Pricing  95k

PBS MoU

Commonwealth of Australia and Medicines Australia Memorandum of Understanding 2010

In May 2010, Medicines Australia (MoU) reached an agreement with the Commonwealth that was enshrined in a Memorandum of Understanding (MoU). The MoU was announced in the Federal Budget 2011-12.

The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2010 was passed by the Australian Parliament in November 2010 to give effect to some of the measures contained in the MoU.

The MoU covers the following issues:

  • strengthened price disclosure arrangements;
  • price reductions for certain drugs listed on the PBS;
  • the creation of new therapeutic groups;
  • the consistent treatment of brands of drugs sold at the same price;
  • comparators;
  • parallel Therapeutic Goods Administration (TGA) and PBAC processes;
  • a managed entry scheme from 1 January 2011;
  • timing and maximum time frames for PBS pricing negotiations and consideration by Cabinet; and
  • resolution of issues in good faith.

  • Memorandum of Understanding (MoU) between the Commonwealth of Australia and Medicines Australia 238k

Page updated: September 2011

Back to top

© 2012 Medicines Australia


  • Copyright Statement
  • Disclaimer Statement
  • Privacy Statement

Level 1, 16 Napier Close
Deakin, ACT, 2600, Australia

Work: +61 2 6122 8500   Fax: +61 2 6122 8555
Email: info@medicinesaustralia.com.au